Abstract
Background and aims
After partial gastrectomy, the mucosa of the residual stomach usually undergoes severe changes, and these lesions are known to be pre-cancerous. Recently, Helicobacter pylori has been highlighted as an agent that induces such mucosal alterations. In the present study, we evaluated whether eradication of H. pylori reduced the risk of carcinogenesis.
Patients and methods
The subjects were 12 patients who underwent distal gastrectomy with Billroth I anastomosis for early gastric cancer and were positive for H. pylori. We performed endoscopy and biopsy both before and after H. pylori eradication therapy to assess changes in the gastric mucosa.
Results
After eradication therapy, no mucosal edema or erythema was detected. On histological examination, mononuclear cell infiltration had decreased and there was complete absence of neutrophil infiltration. The Ki-67 labeling index and the tissue IL-8 level had also decreased significantly, compared with before eradication.
Conclusion
Before H. pylori eradication, the mucosa of the residual stomach may be at high risk of carcinogenesis due to induction of mucosal damage and active gastritis by H. pylori. Such changes were almost completely normalized by eradication therapy, so the eradication of H. pylori may reduce the risk of H. pylori-associated carcinogenesis in patients who have undergone gastrectomy for early gastric cancer.
Similar content being viewed by others
References
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perz GI, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136
Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY (1994) Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691–2694
Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M, Terada M, Sugimura T (1995) Helicobacter pylori Infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 86:64–71
Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y and the research group on prevention of gastric carcinoma among young adults (1995) Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75:2789–2793
International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Scientific Publication no 61, Lyon, pp 177–240
Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639–642
The European Helicobacter pylori study group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8–13
Langhans P, Bues M, Bunte H (1984) Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years. Scand J Gastroenterol 19 [Suppl 92]:145–148
Weinstein WM, Buch KL, Elashoff J, Reedy T, Tedesco FJ, Samloff IM, Ippoliti AF (1985) The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol 20 [Suppl 109]:77–89
Domellof L (1979) Gastric carcinoma promoted by alkaline reflux gastritis—with special reference to bile and other surfactants as promoters of post-operative gastric cancer. Med Hypotheses 554:63–76
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740
Safatle-Ribeilo AV, Ribeilo U Jr, Clarke MR, Sakai P, Ishioka S, Garido AB Jr, Gama-Rodrigues J, Safatle NF, Reynolds JC (1999) Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 2:243–252
Kurihara N, Kubota T, Ohtani Y, Kumai K, Kitazima M (1995) High incidence of Helicobacter pylori infection detected serologically in the residual stomach by gastric cancer. Oncol Rep 4:103–106
Katsube T, Ogawa K, Hamaguchi K, Murayama M, Konno S, Shimakawa T, Naritaka Y, Yagaw H, Kajiwara T, Aiba M (2002) Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer. Hepatogastroenterology 49:128–132
Hiker E, Domske W, Stoll R (1996)13C-urea breath test for detection of Helicobacter pylori and its correlation with endoscopic and histologic findings. J Physiol Pharmacol 47:79–90
Yamamoto Y, Kouda M, Abe K. Sakurabayashi S, Sezai S, Hirano M, Oka H (1995) Detection of Helicobacter pylori by culture and the 13C-urea breath test using an automated breath 13C analyzer. JSGE 92:1839–1845
Graham PD, Klein PD, Evance DJ Evance DG, Alpert LC, Opekum AR, Boutton TW (1987) Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet i:1174–1177
Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY (1996) Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C-urea breath test. Am J Gastroenterol 91:690–694
Ohara S, Kato M, Asaka M, Toyota T (1998) Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 33:6–13
Lotterler E, Ludtke FE, Tegeler R, Lepsien G, Bauer FE (1993) The 13C-urea breath test-detection of Helicobacter pylori infection in patients with partial gastrectomy. Z Gastroenterol 31:115–119
American Digestive Health Foundation (1997) The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 113:4–8
Tytgat GNJ (1991) The Sydney system: endoscopic division. Endoscopic appearance in gastritis/duodenitis. J Gastroenterol Hepatol 6:223–234
Dixson MF, Genta RM, Yardley JH, Crrea P (1996) Classification and grading of gastritis. The update Sydney system. Am J Surg Pathol 20:1161–1181
Bradford MA (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
Endo I, Sugiyama M, Yamamoto T, Katamura H (1992) The role of Helicobacter pylori on gastritis occurring in the gastric stump. Ther Res 13:2653–2656
Kiyozaki H, Nei J, Hayase M (1993) The role of Helicobacter pylori in gastritis after distal partial gastrectomy. Gastroenterol Endosc 35:9–14
Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y (1996) Etiological involvement of Helicobacter pylori in reflux gastritis after gastrectomy. Am J Gastroenterol 91:2130–2134
Kurihara N, Kubota T, Hayashi N, Ishizuka H, Hoshiya Y, Sakurai Y, Yoshida M, Murayama Y, Ohtani Y, Kumai H, Kitazima M (1995) Gastritis in the residual stomach and Helicobacter pylori infection. Gastroenterol Endosc 37:2441–2445
Leivonen MK, Haglund CH, Nordling SFA (1997) Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol 9:371–374
Miwa H, Hirose M, Kikuchi S, Terai T, Iwazaki R, Kobayashi O, Takei Y, Ogihara T, Sato N (1999) How useful is the detection kit for antibody in urine (URINELISA) in clinical practice? Am J Gastroenterol 94:3460–3463
Buruk F, Berberoglu U, Pak I, Aksaz E, Celen O (1993) Gastric cancer and Helicobacter pylori infection. Br J Surg 80:378–379
Sipponen P, Seppala K (1992) Gastric carcinoma: failed adaptation to Helicobacter pylori. Scand J Gastroenterol 27:33–38
Sipponen P, Hyvarinen H (1993) Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 28:3–6
Correa P, Ruiz B, Shi TY, Janney A, Sobhan M, Torrado J, et al (1994) Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 101:656–660
Fan XG, Kelleher D, Fan XL, Xia HX, Keeling PWN (1996) Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 38:19–22
Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I (1997) Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 108:26–34
Lynch DAF, Mapstone NP, Clarke AMT, Jackson P, Dixon MF, Quirke P (1995) Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 36:351–353
Leivonen M, Nordling S, Haglund C(1997) Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 17:3893–3896
Blaser MJ (1992) Hypotheses on the pathogenesis and natural history of Helicobacter pylori -induced inflammation. Gastroenterology 102:720–727
Cover TL, Blaser MJ (1992) Helicobacter pylori and gastroduodenal disease. Annu Rev Med 43:135–145
Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049
Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9:617–648
Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS (1994) Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 29:419–424
Ohkusa T, Kumagai J, Tanizawa T (1998) Changes in endoscopic features of H. pylori-related gastritis with follow-up over a year after eradication of H. pylori, measured according to the Sydney system. Gastroenterol Endosc 10:1001–1008
Kawakita N, Nagahata Y, Azumi Y, Wada T, Numata N, Saitoh Y (1995) Residual gastritis after gastrectomy and Helicobacter pylori—Its clinical significance. Jpn J Gastroenterol 92:862–869
Rauws EJ, Langenberg W, Houthoff HJ, Zanen HC, Tygat GN (1988) Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40
Murakami K, Fujioka T, Kodama R, Kubota T, Tokieda M, Nasu M (1997) Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 32:184–188
Shijou Y (1998) Gastric epithelial cell proliferation before and after eradication therapy of Helicobacter pylori. An immunohistochemical study. J Tokyo Women Med Univ 68:123–130
Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Shi TY (1993) Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88:1870–1875
Zang QB, Dawodu JB, Husain A, Etohli G, Gemmell CG, Russell RI (1997) Association of antral mucosal levels of interleukin-8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci 92:69–73
Ito M, Haruma K, Kamada T, Mihara M, Kim S, KItadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Alimental Pharmacol Ther 16:1449–1456
Nordone G, Staibano S, Rocco A, Mezza E, D’Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Fugura N, De Rosa G, Budillon G (1999) Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 44:789–799
Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, Nasu M (1999) Analysis of p53 gene mutations in Helicobacter pylori -associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 34:474–477
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamaguchi, K., Ogawa, K., Katsube, T. et al. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer?. Langenbecks Arch Surg 389, 83–91 (2004). https://doi.org/10.1007/s00423-003-0451-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-003-0451-x